Table 3. Initial, final, and relative change in GCL, RNFL and VA for anti-MOG cohort.
Parameters | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Average |
GCL | 65, 62, -3 | 84, 62, -12 | 85, 82, -3 | 83, 56, -26 | 61, 58, -3 | 76, 81, +5 | 34, 35, +1 | 73, 50, -23 | 80, 72, -8 | 54, 52, -2 | 79, 78, -1 | 33, 73, +40 | 67.23, 63.42, -2.92 |
RNFL | 104, 60, -44 | 175, 88, -87 | 114, 91, -23 | 139, 57, -82 | 55, 55, 0 | 94, 92, -2 | 379, 86, -293 | 235, 47, -188 | 203, 80, -123 | 58, 58, 0 | 143, 110, -33 | 254, 84, 170 | 162.75, 75.67, -58.75 |
VA | 1, 0, -1 | 1, 0.2, -0.8 | 0.1, 0.1, 0 | 1, 0.5, -0.5 | 2.1, 0.1, -2 | 0.3, 0.2, -0.1 | 2.1, 0, -2.1 | 1, 0.1, -0.9 | 0.2, 0, -0.2 | 0.5, 0.2, -0.3 | 0.5, 0, -0.5 | 0, 0.1, +0.1 | 0.82, 0.13, -0.66 |
GCL: Ganglion cell layer; RNFL: Retinal nerve fiber layer; VA: Visual acuity.
initial, final, change; µm